Lv2
180 积分 2023-06-01 加入
Immune Reprogramming of Tumor Microenvironments by Cytotoxic Antibody–Drug Conjugate Payloads
2小时前
待确认
Safety and pharmacokinetics of SOR102, an oral bispecific inhibitor of TNF and interleukin-23 in healthy participants and patients with ulcerative colitis: a first-in-human, double-blind, randomised, placebo-controlled, phase 1 trial
4个月前
已完结
Peste des petits ruminants virus-like particles induce both complete virus-specific antibodies and virus neutralizing antibodies in mice
5个月前
已完结
Lymphocyte activation gene-3 induces tumor regression and antitumor immune responses
5个月前
已完结
Tocilizumab increases regulatory T cells, reduces natural killer cells and delays graft‐versus‐host disease development in humanized mice treated with post‐transplant cyclophosphamide
8个月前
已完结
皖公网安备34019202002308
